Cargando…

Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily

BACKGROUND: Reduced libido is widely considered the most prominent symptomatic reflection of low testosterone (T) levels in men. Testosterone deficiency (TD) afflicts approximately 30% of men aged 40-79 years. This study seeks to evaluate the effect of a new natural compound “tradamixina “in order t...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacono, Fabrizio, Prezioso, Domenico, Illiano, Ester, Romeo, Giuseppe, Ruffo, Antonio, Amato, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499213/
https://www.ncbi.nlm.nih.gov/pubmed/23173697
http://dx.doi.org/10.1186/1471-2482-12-S1-S23
_version_ 1782249919534333952
author Iacono, Fabrizio
Prezioso, Domenico
Illiano, Ester
Romeo, Giuseppe
Ruffo, Antonio
Amato, Bruno
author_facet Iacono, Fabrizio
Prezioso, Domenico
Illiano, Ester
Romeo, Giuseppe
Ruffo, Antonio
Amato, Bruno
author_sort Iacono, Fabrizio
collection PubMed
description BACKGROUND: Reduced libido is widely considered the most prominent symptomatic reflection of low testosterone (T) levels in men. Testosterone deficiency (TD) afflicts approximately 30% of men aged 40-79 years. This study seeks to evaluate the effect of a new natural compound “tradamixina “in order to improve male sexual function in elderly men, particularly libido and possible erectile dysfunction, versus administration of tadalafil 5 mg daily. METHODS: Seventy patients (67.3± 3.7 years) with stable marital relations and affected by reduced libido, with or without erectile dysfunction were recruited. They were randomly separated in 2 groups A-B of 35. Group A was administered twice a day a new compound “Tradamixina” (150 mg of Alga Ecklonia Bicyclis, 396 mg of Tribulus Terrestris and 144 mg of D-Glucosamine and N-Acetyl-D-Glucosamine) for two months, while Group B was administered tadalafil 5 mg daily, for two months. At visit and after 60 days of treatment patients were evaluated by means of detailed medical and sexual history, clinical examination, laboratory investigations (Total and Free T), instrumental examination (NPTR- nocturnal penile tumescence and rigidity test- with Rigiscan). Patients completed a self-administered IIEF questionnaire (The international index of erectile function) and SQoLM questionnaire (Sexual quality of life Questionnarie-Male). The results pre and post treatment were compared by Student t test (p<0.005). RESULTS: After 2 months of treatment in group A serum TT levels (230±18 ng/dl vs 671±14 ng/dl ) and FT levels(56± 2.4 pg/ml vs 120± 3.9pg/ml) increased, while in group B serum TT levels (245±12 ng/dl vs 247±15 ng/dl ) and FT levels(53± 0.3 pg/ml vs 55± 0.5pg/ml) increased not statistically significant. The patient’s numbers with negative NPTR improved after treatment in group A and B (15 vs 18 and 13 vs 25 respectively). The IIEF total score in group A increased after treatment with tradamixina (15±1.5 vs 29.77±1.2); the IIEF total score in group B increased slightly (12±1.3 vs 23.40±1.2). The SQoLM total score improved in both groups (A:16±2,3 vs 33±4,1 and B: 16±3,4 vs 31±2,1). CONCLUSION: The treatment twice a day with “Tradamixina” for 2 months improved libido in elderly men without side effects of Tadalafil.
format Online
Article
Text
id pubmed-3499213
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34992132012-11-20 Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily Iacono, Fabrizio Prezioso, Domenico Illiano, Ester Romeo, Giuseppe Ruffo, Antonio Amato, Bruno BMC Surg Research Article BACKGROUND: Reduced libido is widely considered the most prominent symptomatic reflection of low testosterone (T) levels in men. Testosterone deficiency (TD) afflicts approximately 30% of men aged 40-79 years. This study seeks to evaluate the effect of a new natural compound “tradamixina “in order to improve male sexual function in elderly men, particularly libido and possible erectile dysfunction, versus administration of tadalafil 5 mg daily. METHODS: Seventy patients (67.3± 3.7 years) with stable marital relations and affected by reduced libido, with or without erectile dysfunction were recruited. They were randomly separated in 2 groups A-B of 35. Group A was administered twice a day a new compound “Tradamixina” (150 mg of Alga Ecklonia Bicyclis, 396 mg of Tribulus Terrestris and 144 mg of D-Glucosamine and N-Acetyl-D-Glucosamine) for two months, while Group B was administered tadalafil 5 mg daily, for two months. At visit and after 60 days of treatment patients were evaluated by means of detailed medical and sexual history, clinical examination, laboratory investigations (Total and Free T), instrumental examination (NPTR- nocturnal penile tumescence and rigidity test- with Rigiscan). Patients completed a self-administered IIEF questionnaire (The international index of erectile function) and SQoLM questionnaire (Sexual quality of life Questionnarie-Male). The results pre and post treatment were compared by Student t test (p<0.005). RESULTS: After 2 months of treatment in group A serum TT levels (230±18 ng/dl vs 671±14 ng/dl ) and FT levels(56± 2.4 pg/ml vs 120± 3.9pg/ml) increased, while in group B serum TT levels (245±12 ng/dl vs 247±15 ng/dl ) and FT levels(53± 0.3 pg/ml vs 55± 0.5pg/ml) increased not statistically significant. The patient’s numbers with negative NPTR improved after treatment in group A and B (15 vs 18 and 13 vs 25 respectively). The IIEF total score in group A increased after treatment with tradamixina (15±1.5 vs 29.77±1.2); the IIEF total score in group B increased slightly (12±1.3 vs 23.40±1.2). The SQoLM total score improved in both groups (A:16±2,3 vs 33±4,1 and B: 16±3,4 vs 31±2,1). CONCLUSION: The treatment twice a day with “Tradamixina” for 2 months improved libido in elderly men without side effects of Tadalafil. BioMed Central 2012-11-15 /pmc/articles/PMC3499213/ /pubmed/23173697 http://dx.doi.org/10.1186/1471-2482-12-S1-S23 Text en Copyright ©2012 Iacono et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Iacono, Fabrizio
Prezioso, Domenico
Illiano, Ester
Romeo, Giuseppe
Ruffo, Antonio
Amato, Bruno
Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
title Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
title_full Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
title_fullStr Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
title_full_unstemmed Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
title_short Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
title_sort sexual asthenia: tradamixina versus tadalafil 5 mg daily
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499213/
https://www.ncbi.nlm.nih.gov/pubmed/23173697
http://dx.doi.org/10.1186/1471-2482-12-S1-S23
work_keys_str_mv AT iaconofabrizio sexualastheniatradamixinaversustadalafil5mgdaily
AT preziosodomenico sexualastheniatradamixinaversustadalafil5mgdaily
AT illianoester sexualastheniatradamixinaversustadalafil5mgdaily
AT romeogiuseppe sexualastheniatradamixinaversustadalafil5mgdaily
AT ruffoantonio sexualastheniatradamixinaversustadalafil5mgdaily
AT amatobruno sexualastheniatradamixinaversustadalafil5mgdaily